CO-ADD (Community for Open Antimicrobial Drug Discovery)

Therapeutic Approaches: Small Molecules

Therapeutic Areas of Expertise: Infectious Diseases

Center/Program Highlights: CO-ADD is a not-for-profit initiative led by academics.

Our goal is to screen compounds for antimicrobial activity for academic research groups from anywhere in the world for free. We make no claim to IP or results.

We aim to help researchers around the world to find new, diverse compounds to combat the superbug crisis.

CO-ADD is a global initiative of The University of Queenslands Institute for Molecular Bioscience and is funded by the Wellcome Trust and The University of Queensland. We are reaching out to chemists in academia and research organisations who have compounds sitting on shelves that were not designed as antibiotics and would not otherwise be screened for antimicrobial activity.
from academic research groups

Sources of Funding: Philanthropy, University

Website

Institutional Affiliation(s): The University of Queensland, Wellcome Trust

Address:
Institute for Molecular Bioscience
The University of Queensland Bld 80
Brisbane
QLD, 4072
Australia

Center/Program Start Date: 2015

Number of Employees: 15